• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌及癌旁组织配对临床样本的高分辨魔角旋转核磁共振波谱分析。

High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy of Paired Clinical Liver Tissue Samples from Hepatocellular Cancer and Surrounding Region.

机构信息

The Roger Williams Institute of Hepatology, Foundation for Liver Research, 111 Coldharbour Lane, London SE5 9NT, UK.

Faculty of Life Sciences & Medicine, King's College London, London WC2R 2LS, UK.

出版信息

Int J Mol Sci. 2024 Aug 16;25(16):8924. doi: 10.3390/ijms25168924.

DOI:10.3390/ijms25168924
PMID:39201610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11354908/
Abstract

The global burden of liver cancer is increasing. Timely diagnosis is important for optimising the limited available treatment options. Understanding the metabolic consequences of hepatocellular carcinoma (HCC) may lead to more effective treatment options. We aimed to document metabolite differences between HCC and matched surrounding tissues of varying aetiology, obtained at the time of liver resection, and to interpret metabolite changes with clinical findings. High-resolution magic angle spinning nuclear magnetic resonance (HRMAS-NMR) spectroscopy analyses of N = 10 paired HCC and surrounding non-tumour liver tissue samples were undertaken. There were marked HRMAS-NMR differences in lipid levels in HCC tissue compared to matched surrounding tissue and more subtle changes in low-molecular-weight metabolites, particularly when adjusting for patient-specific variability. Differences in lipid-CH, lipid-CH, formate, and acetate levels were of particular interest. The obvious differences in lipid content highlight the intricate interplay between metabolic adaptations and cancer cell survival in the complex microenvironment of liver cancer. Differences in formate and acetate might relate to bacterial metabolites. Therefore, documentation of metabolites in HCC tissue according to histology findings in patients is of interest for personalised medicine approaches and for tailoring targeted treatment strategies.

摘要

全球肝癌负担正在增加。及时诊断对于优化有限的可用治疗选择非常重要。了解肝细胞癌 (HCC) 的代谢后果可能会导致更有效的治疗选择。我们旨在记录肝癌切除时获得的不同病因 HCC 和匹配的周围组织之间的代谢物差异,并根据临床发现解释代谢物变化。对 N = 10 对 HCC 和匹配的非肿瘤肝组织样本进行了高分辨率魔角旋转核磁共振 (HRMAS-NMR) 光谱分析。与匹配的周围组织相比,HCC 组织中的脂质水平存在明显的 HRMAS-NMR 差异,而低分子量代谢物的变化则更为微妙,尤其是在考虑患者特异性变异性时。脂质-CH、脂质-CH、甲酸盐和乙酸盐水平的差异特别有趣。脂质含量的明显差异突出了代谢适应与肝癌复杂微环境中癌细胞存活之间的复杂相互作用。甲酸盐和乙酸盐的差异可能与细菌代谢物有关。因此,根据患者的组织学发现记录 HCC 组织中的代谢物对于个性化医疗方法和定制靶向治疗策略很有意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/7e50dc2b1fdd/ijms-25-08924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/4995550ad51f/ijms-25-08924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/fc32be196e9c/ijms-25-08924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/d86cd79c6081/ijms-25-08924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/17e425c95a10/ijms-25-08924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/826737d710b0/ijms-25-08924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/6c4225492c4a/ijms-25-08924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/7e50dc2b1fdd/ijms-25-08924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/4995550ad51f/ijms-25-08924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/fc32be196e9c/ijms-25-08924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/d86cd79c6081/ijms-25-08924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/17e425c95a10/ijms-25-08924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/826737d710b0/ijms-25-08924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/6c4225492c4a/ijms-25-08924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c4/11354908/7e50dc2b1fdd/ijms-25-08924-g007.jpg

相似文献

1
High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy of Paired Clinical Liver Tissue Samples from Hepatocellular Cancer and Surrounding Region.肝癌及癌旁组织配对临床样本的高分辨魔角旋转核磁共振波谱分析。
Int J Mol Sci. 2024 Aug 16;25(16):8924. doi: 10.3390/ijms25168924.
2
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
3
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
4
In vivo detection of metabolic changes by 1H-MRS in the DEN-induced hepatocellular carcinoma in Wistar rat.通过1H-MRS对Wistar大鼠二乙基亚硝胺诱导的肝细胞癌进行体内代谢变化检测。
J Cancer Res Clin Oncol. 2005 Sep;131(9):597-602. doi: 10.1007/s00432-005-0684-x. Epub 2005 Oct 20.
5
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
6
Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma.细菌代谢产物丁酸盐通过调节索拉非尼靶向 microRNAs 来抑制肝癌的耐药性。
J Cancer Res Clin Oncol. 2023 Aug;149(9):5823-5839. doi: 10.1007/s00432-022-04544-7. Epub 2022 Dec 30.
7
Gene therapy for people with hepatocellular carcinoma.肝细胞癌的基因治疗。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013731. doi: 10.1002/14651858.CD013731.pub2.
8
Metabolic self-feeding in HBV-associated hepatocarcinoma centered on feedback between circulation lipids and the cellular MAPK/mTOR axis.基于循环脂质与细胞 MAPK/mTOR 轴之间的反馈,HBV 相关肝癌中的代谢自养。
Cell Commun Signal. 2024 May 21;22(1):280. doi: 10.1186/s12964-024-01619-5.
9
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.经皮乙醇注射或经皮乙酸注射治疗早期肝细胞癌。
Cochrane Database Syst Rev. 2015 Jan 26;1(1):CD006745. doi: 10.1002/14651858.CD006745.pub3.
10
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.IGF2 通过表观遗传机制在肝细胞癌中上调,并且是实验模型中可操作的癌基因产物。
Gastroenterology. 2016 Dec;151(6):1192-1205. doi: 10.1053/j.gastro.2016.09.001. Epub 2016 Sep 7.

本文引用的文献

1
Applications of single-cell multi-omics in liver cancer.单细胞多组学在肝癌中的应用。
JHEP Rep. 2024 Apr 15;6(7):101094. doi: 10.1016/j.jhepr.2024.101094. eCollection 2024 Jul.
2
Distinctly altered lipid components in hepatocellular carcinoma relate to impaired T cell-dependent antitumor immunity.肝癌中明显改变的脂质成分与 T 细胞依赖性抗肿瘤免疫受损有关。
Hepatol Int. 2024 Apr;18(2):582-594. doi: 10.1007/s12072-023-10595-w. Epub 2023 Oct 12.
3
Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing.
原发性肝癌患者来源的精确切割组织切片作为临床前药物测试的潜在平台。
EBioMedicine. 2023 Nov;97:104826. doi: 10.1016/j.ebiom.2023.104826. Epub 2023 Oct 10.
4
Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma.肠道微生物组作为预测乙型肝炎病毒相关肝细胞癌早期复发的生物标志物。
Cancer Sci. 2023 Dec;114(12):4717-4731. doi: 10.1111/cas.15983. Epub 2023 Oct 1.
5
Bioactive signalling lipids as drivers of chronic liver diseases.生物活性信号脂质作为慢性肝脏疾病的驱动因素。
J Hepatol. 2024 Jan;80(1):140-154. doi: 10.1016/j.jhep.2023.08.029. Epub 2023 Sep 21.
6
Formate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade.补充甲酸盐可增强抗肿瘤 CD8+T 细胞的适应性和 PD-1 阻断的疗效。
Cancer Discov. 2023 Dec 12;13(12):2566-2583. doi: 10.1158/2159-8290.CD-22-1301.
7
Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond.肠道-肝脏轴在非酒精性脂肪性肝病/非酒精性脂肪性肝炎、肝癌及其他疾病发病机制中的作用的最新研究进展。
Hepatol Commun. 2023 Aug 28;7(9). doi: 10.1097/HC9.0000000000000241. eCollection 2023 Sep 1.
8
Limosilactobacillus fermentum, Lactococcus lactis and Thomasclavelia ramosa are enriched and Methanobrevibacter smithii is depleted in patients with non-alcoholic steatohepatitis.非酒精性脂肪性肝炎患者中富含发酵乳杆菌、乳球菌乳亚种和罗氏唐松草分枝杆菌,而减少了产甲烷短杆菌。
Microb Pathog. 2023 Jul;180:106160. doi: 10.1016/j.micpath.2023.106160. Epub 2023 May 20.
9
Prognostic Scores and Survival Rates by Etiology of Hepatocellular Carcinoma: A Review.肝细胞癌病因的预后评分与生存率:综述
J Clin Med Res. 2023 Apr;15(4):200-207. doi: 10.14740/jocmr4902. Epub 2023 Apr 28.
10
The Global Burden of Liver Disease.《全球肝脏疾病负担》
Clin Gastroenterol Hepatol. 2023 Jul;21(8):1978-1991. doi: 10.1016/j.cgh.2023.04.015. Epub 2023 Apr 28.